« Newsweek reporting significantly accurate computer thought decoding study | Main | California stem cell research company produces two human embryonic clones »

January 17, 2008

SciVestor Corporation launches Singularity-related technology research offerings

I spoke with Jonas Lamis, Executive Director of SciVestor Corporation regarding the launch of SciVestor this month. SciVestor is a research and advisory company focused on key Singularity technologies, and provides valuable insight as to the effects these emergent technologies will have on business, economic and societal models. SciVestor offers research reports that I believe are of value to investors who are looking to improve their investment strategies. Here is some key information that I have summarized from the SciVestor web site:

  • Robotics
    The robotics industry is expected to grow from $5B in 2007 to $50B in 2012. SciVestor believes the age of intelligent machines is at hand. From service robots to toys and teachers to companionship to war-fighting, the decade ahead will see a dramatic acceleration in human robot interaction (HRI).

  • Nanotechnology
    The rise of molecular manufacturing over the next decade portends a transformation across the supply and delivery chains. Traditional manufacturing enterprises could be displaced by distributed fabrication capabilities. Intellectual property rights for brands and designs will rise to the forefront when perfect replicas become commonplace.

  • Artificial Intelligence
    The software development marketplace is on a steady march to automation of more complex tasks and processes. In the decade ahead, we will see the rise of complex AI capabilities that will take ownership of virtually every repetitive digital task that could be automated. This shift will create significant disruptions in many career roles as well as with outsourcing companies that rely on human capital for efficiencies.

  • Life Extension
    At the intersection of genetics, biotechnology and Moore’s Law lies the new science of life extension. Over the next decade, we will see medical technologies deliver designer therapies targeting disease and degeneration on an individual basis. By 2015, we estimate that more than 10% of first world medical expenses will be devoted to life extension treatments, and many senior citizens in 2050 will have substantially lengthened, productive lifespans.

Jonas Lamis has extensive experience in corporate strategy, business development, and technology marketing with venture-backed enterprise software companies. He is Director of Partnerships at the Singularity Institute for Artificial Intelligence. He is the founding editor of Architecture and Governance Magazine, authors the weblog Singularity U and co-launched RobotCentral.com. Jonas received his MBA from The University of Texas at Austin, an MS in Systems Engineering and Optimization from Georgia Institute of Technology, and a BS in Industrial Engineering from Purdue University.

Chris K. Haley, NestedUniverse.net. Subscribe Get free RSS or email updates here. 

Comments


Sponsors